
FDA rejects Intercept’s NASH drug, prompting a pivot
The Food and Drug Administration rejected Intercept Pharmaceuticals’ investigational treatment for NASH on Thursday, derailing what would have been the first approved medicine for a
The Food and Drug Administration rejected Intercept Pharmaceuticals’ investigational treatment for NASH on Thursday, derailing what would have been the first approved medicine for a
Medical device makers may soon have an easier path to securing health insurance reimbursement for their products, following the notice Thursday of a long-awaited rule
Congress is taking early steps towards changing the way Medicare pays physicians. At a hearing Thursday, lawmakers in both parties talked about overhauling a 2015
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered
When I was diagnosed with Duchenne muscular dystrophy 20 years ago, there was no hope. The guidance the diagnosing doctor gave my parents was simple:
WASHINGTON — The health care system is on the precipice of broad access to a treatment for Alzheimer’s for the first time — and it’s scrambling
What You Should Know: Allurion, a company dedicated to ending obesity launches a pilot collaboration agreement with Medtronic to expand access to Allurion’s AI-powered weight
What You Should Know: DUOS, a digital health company focused on empowering older adults to live independently, announced today an additional $10M in funding led
What You Should Know: TELUS Health today released its monthly Mental Health Index which revealed that workers who collaborate with others in the workplace have
What You Should Know: AccurKardia, Inc., a New York-based medical AI software company delivering clinical-grade ECG interpretation software to cardiac monitoring companies raises $2.7M in